Nutrition as a Determinant of Labor Outcome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00367549
Recruitment Status : Completed
First Posted : August 23, 2006
Last Update Posted : July 6, 2011
University of Oslo
Information provided by:
Oslo University Hospital

Brief Summary:
This is a randomized, double-blind trial looking at how nutrition intake is associated with labor progress and complications.

Condition or disease Intervention/treatment
Labor, Obstetric Dietary Supplement: Energy-containing soft drink

Detailed Description:
Insufficient intake of energy during labor may result in poor labor progress. The study investigates the effect of an energy supplement during labor.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 200 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Nutrition as Determinant of Labor Outcome
Study Start Date : September 2006
Primary Completion Date : October 2008
Study Completion Date : December 2009

Intervention Details:
    Dietary Supplement: Energy-containing soft drink
    Commercial energy/sports drink

Primary Outcome Measures :
  1. The course of the labor by women (parity 0) at gestational age > 36 weeks, including: total labor time [ Time Frame: At time of birth ]

Secondary Outcome Measures :
  1. Length of stage 1 (cervical opening < 10 cm) and stage 2 (pushing time)
  2. Use of epidural anesthetics
  3. Use of contraction-stimulating drugs
  4. Instrumental delivery

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Women at gestational age > 36 weeks, parity 0

Exclusion Criteria:

  • Gestational age < 36 weeks
  • Signs of fetal pathology:

    • Different or abnormal (pathological) CTG test performed just before start of the test
    • Abnormal Doppler registrations (PI in the arteria umbilicae > 2SD for the gestational age)
    • Established notch in the arteria uterinae or notch bilaterally or PI > 2SD > 24 weeks
    • Diverging in the weight of the fetus > - 22% or diverging in the growth of the fetus - 10% or more, and established structural pathology in the fetus, oligohydramnion (amniotic fluid index < 6)
  • Maternal diseases and pregnancy complications

    • diabetes in pregnancy
    • high blood pressure
    • cardiovascular diseases
    • rheumatic disease
    • epilepsia
    • lung disease, etc.

CTG test: cardiotocographic test (a measure of fetal activity)

PI: pulsatory index (velocity pattern)

SD: standard deviation

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00367549

Kristin Kardel
Oslo, Norway, 0027
Sponsors and Collaborators
Oslo University Hospital
University of Oslo
Principal Investigator: Tore Henriksen, MD Oslo University Hospital

Responsible Party: Kristin Kardel, Stip., Rikshospitalet University Hospital Identifier: NCT00367549     History of Changes
Other Study ID Numbers: REK-SØR: S-05308
First Posted: August 23, 2006    Key Record Dates
Last Update Posted: July 6, 2011
Last Verified: May 2010

Keywords provided by Oslo University Hospital:
instrumental delivery
epidural anesthesia